MedTrace Logo

In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome

NCT01354275 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2012-02-03

No results posted yet for this study

Summary

Outcomes of IVF/ICSI cycles of women with PCOS undergoing Gonadotropin Releasing Hormone (GnRH) agonist and GnRH Antagonist fixed protocol.

Conditions

  • PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles

Interventions

OTHER

To compare the IVF/ICSI outcomes of GnRH Antagonist cycle versus GnRH agonist cycle

150 IU FSH dose and OCP plus GnRH Agonist (long luteal) IVF/ICSI cycle and 150 IU FSH dose and OCP plus GnRH Antagonist (Fixed protocol) IVF/ICSI Cycle

OTHER

GnRH Antagonist

GnRH Antagonist cycle; 150 IU FSH and sixth day Antagonist will be administered

Sponsors & Collaborators

  • Bulent Haydardedeoglu

    lead OTHER

Principal Investigators

  • Bulent Haydardedeoglu, M.D. · Baskent University

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-03-31
Completion
2011-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01354275 on ClinicalTrials.gov